We have previously conducted several studies on the role of MSI, methylation of cancer related genes and mutations of known genes such as BRAF and KRAS, as well as microarray based studies of CRC tumors from different patients' populations [26],[27],[29],[30],[34],[36],[37]. The gene discussed is BRAF; the disease is cancer.